SC 13D Filing

Company

Petros Pharmaceuticals, Inc.

Filed

December 11, 2020

Accession Number

0000929638-20-001140

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →